Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is a significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological...
Athersys, Inc. The solid gain came after the company and the University of Texas Health Science Center at Houston announced the enrollment of the first patient in a phase 2 clinical study evaluating the company's MultiStem cell therapy as a potential early treatment for traumatic injuries. The company doesn't have any approved products on the market ye t, so...
ATHX recently broke out of a descending wedge that took it from the top of the channel to the bottom...after 9 weeks of consolidation, it is now trading above all major moving averages...monday saw a break above the 200 day ma and today saw a retest...macd is in positive territory and looks to be holding...target for descending wedge coincides nicely with the top...
ATHX has a near doom death cross approaching as the 50 DEMA is coming close to the 200 DEMA. Overall, outside chance here for a WXYXZ correction to be taking place, but where Z finishes remains unknown. RSI is low to nearing oversold. Will try to provide update next week. Do not take as financial advice.
This one, though seemingly violent at times, has followed a complete and natural ABC Correction (as well as a proper ABC within each of these legs as well, broken down above) after a big first leg up. Expectations for a strong 3rd wave - C Wave up (abCde) are growing by the day. As you can see, the resistance that has been hit multiple times since April has...
The stock has had a complete breakdown to retest the Daily 150 EMA. There is a decisive moment ahead to see if there is a rebound off said EMA.
Here is an update to yesterday, a quick, sharp ABC recovery has taken place. Time will tell if this results in this being just the first of a more complex ABC or if this restocked the stochastic enough to propel it onward.
Purely for my own use as I've been following this (as well as a few other stocks since COVID surged this market sector) for a couple months now. I see 3 options ahead of us after the immediate rejection today near 3.30 mark. 1) A quick correction before another rise after another bounce off the support 2) A two week correction before a bounce off support to...
Good Morning, and welcome to my first analysis that is NOT a cryptocurrency! Today we will be analyzing Anthersys ( ATHX ). ATHX has had a rough time recently and after hitting a 52 week high of $2.63 in September of 2017 it has dropped roughly 45%. Lets take a look at the chart. The first thing we can see is that we are obviously in a downward channel...